
Two vaccine doses may not provide sufficient protection against Omicron coronavirus variant, but protection improves with three doses, Pfizer says
CNN
Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.
Samples from people who had two doses of the Covid-19 vaccine saw, on average, a more than 25-fold reduction in neutralization ability against the Omicron variant than the earlier virus, "indicating that two doses of BNT162b2 may not be sufficient to protect against infection with the Omicron variant," the companies said.

Emil Bove, a top Justice Department official who also defended Donald Trump in his criminal indictments, has been confirmed to a lifetime appointment as a federal appellate judge, despite accusations from a handful of whistleblowers accusing him of improperly overseeing cases for the administration.